Form 4 for CLNN Clene Inc.
Accepted 2023-09-08 00:00:00 ET · period of report 2023-06-16 · accession 0001014108-23-000136 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2023-09-08 | 2023-06-16 | CLNN | Ugwumba Chidozie | 10%, Resigned as Dir 2, 15, 2023 | P - Purchase | $0.8 | +7.50M | 13.02M | +136% | +$6.00M |
| DMI | 2023-09-08 | 2023-06-16 | CLNN | Ugwumba Chidozie | 10%, Resigned as Dir 2, 15, 2023 | A - Grant | — | +15.00M | 7.50M | New | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-06-16 | P | A | 7,500,000 | $0.8 | 13,018,908 | I By Symbiosis II, LLC | — | — | (F1) The price for each Unit is $0.80; one Unit consists of one share of Common Stock of Clene, one Tranche A Warrant and one Tranche B Warrant. |
| 2 | Derivative | Warrants (Right to buy) | 2023-06-16 | A | A | 7,500,000 | — | 7,500,000 | I By Symbiosis II, LLC | $1.10 · 2023-06-16 to — | 7,500,000 Common Stock | (F1) The price for each Unit is $0.80; one Unit consists of one share of Common Stock of Clene, one Tranche A Warrant and one Tranche B Warrant. (F3) The reporting person purchased a unit consisting of one share of Common Stock of Clene Inc., one Tranche A Warrant, and one Tranche B Warrant. The Tranche A Warrant is for 7,500,000 shares of Common Stock of Clene Inc. at an exercise price of $1.10 per share. The Tranche A Warrant will expire on the earlier of (a) June 16, 2026, or (b) 60 days after the Food and Drug Administration accepts a New Drug Application from Clene Inc. |
| 3 | Derivative | Warrants (Right to buy) | 2023-06-16 | A | A | 7,500,000 | — | 7,500,000 | I By Symbiosis II, LLC | $1.50 · 2023-06-16 to — | 7,500,000 Common Stock | (F1) The price for each Unit is $0.80; one Unit consists of one share of Common Stock of Clene, one Tranche A Warrant and one Tranche B Warrant. (F2) The reporting person purchased a unit consisting of one share of Common Stock of Clene Inc., one Tranche A Warrant, and one Tranche B Warrant. The Tranche B Warrant is for 7,500,000 shares of Common Stock of Clene Inc. at an exercise price of $1.50 per share. The Tranche B Warrant will expire on the earlier of (a) June 16, 2030, or (b) 60 days after the Food and Drug Administration accepts a New Drug Application from Clene Inc. |